摘要
Abstract
Objective To explore the clinical effects of different regimens by transcatheter arterial chemoembolization ( TACE ) for treating hepatic cancer and to summarize the nursing experience. Methods 40 cases of hepatic cancer treated by TACE were randomly divided into the control group and the observation group, 20 cases in each group. The chemotherapeutic regimen in the control group was 5-fluorouracil plus doxorubicin plus cisplatin, while which in the observation group was 5-fluorouracil plus doxorubicin plus lobaplatin. At the same time, the two groups were given the targeted perioperative nursing. The total effective rate, KPS score and the incidence of ad-verse reactions were compared between the two groups. Results The total effective rate of the observation group was 65. 00%, which was significantly higher than 45. 00% in the control group, the difference was statistically significant ( P < 0. 05 );the KPS scores after treatment in the observation group were ( 8. 56 ± 9. 97 ) points, which were higher than ( 71. 83 ± 10. 12 ) points in the control group, the difference was statistically significant ( P < 0. 05 ) . The occurrence rate of adverse reactions after treatment in the two groups was 85. 00% with no significant difference ( P > 0. 05 ) . Conclusion TACE adding lobaplatin can significantly increase the total effect for treating primary hepatic cancer, compared with the traditional regimen, the occurrence rate of adverse reactions shows no obvious in-crease. the proper nursing can ensure TACE to be smoothly conducted.关键词
经肝动脉化疗栓塞术/原发性肝癌/洛铂/护理Key words
transcatheter arterial chemoembolization/primary liver cancer/lobaplatin/nursing care分类
医药卫生
